卵泡抑素樣蛋白1(FSTL1)檢測試劑盒(酶聯免疫吸附試驗法)
ELISA Kit for Follistatin Like Protein 1 (FSTL1)
FRP; FSL1; Follistatin-related protein 1
- 編號SEJ085Hu
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 實驗方法雙抗夾心
 - 反應時長3h
 - 檢測范圍1.56-100ng/mL
 - 靈敏度最小可檢測劑量小于等于0.59ng/mL.
 - 樣本類型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
 - 下載英文說明書 中文說明書
 - 規(guī)格48T96T96T*596T*1096T*100
 - 價格¥ 2940¥ 4200¥ 18900¥ 35700¥ 294000
 - 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
 
特異性
                        本試劑盒用于檢測卵泡抑素樣蛋白1(FSTL1),經檢測與其它相似物質無明顯交叉反應。
                        由于受到技術及樣本來源的限制,不可能完成對所有相關或相似物質交叉反應檢測,因此本試劑盒有可能與未經檢測的其它物質有交叉反應。
                    
回收率
分別于定值血清及血漿樣本中加入一定量的卵泡抑素樣蛋白1(FSTL1)(加標樣品),重復測定并計算其均值,回收率為測定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) | 
| serum(n=5) | 78-93 | 83 | 
| EDTA plasma(n=5) | 85-104 | 92 | 
| heparin plasma(n=5) | 79-94 | 82 | 
精密度
                    精密度用樣品測定值的變異系數CV表示。CV(%) = SD/mean×100 
                    批內差:取同批次試劑盒對低、中、高值定值樣本進行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
                    批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進行定量測定,每個樣本使用同一試劑盒重復測定8次,分別計算不同濃度樣本的平均值及SD值。
                    批內差: CV<10% 
                    批間差: CV<12% 
線性
在定值血清及血漿樣本內加入適量的卵泡抑素樣蛋白1(FSTL1),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中卵泡抑素樣蛋白1(FSTL1)含量的測定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 | 
| serum(n=5) | 85-104% | 96-105% | 79-95% | 87-101% | 
| EDTA plasma(n=5) | 79-96% | 88-95% | 95-103% | 78-92% | 
| heparin plasma(n=5) | 88-95% | 92-101% | 90-97% | 83-95% | 
穩(wěn)定性
                    經測定,試劑盒在有效期內按推薦溫度保存,其活性降低率小于5%。
                    為減小外部因素對試劑盒破壞前后檢測值的影響,實驗室的環(huán)境條件需盡量保持一致,尤其是實驗室內溫度、濕度及溫育條件。其次由同一實驗員來進行操作可減少人為誤差。
                
實驗流程
1. 實驗前標準品、試劑及樣本的準備;
                            2. 加樣(標準品及樣本)100µL,37°C孵育1小時;
                            3. 吸棄,加檢測溶液A100µL,37°C孵育1小時;
                            4. 洗板3次;
                            5. 加檢測溶液B100µL,37°C孵育30分鐘;
                            6. 洗板5次;
                            7. 加TMB底物90µL,37°C孵育10-20分鐘;
                            8. 加終止液50µL,立即450nm讀數。
實驗原理
將卵泡抑素樣蛋白1(FSTL1)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標準品或標本,其中的卵泡抑素樣蛋白1(FSTL1)與連接于固相載體上的抗體結合,然后加入生物素化的卵泡抑素樣蛋白1(FSTL1)抗體,將未結合的生物素化抗體洗凈后,加入HRP標記的親和素,再次徹底洗滌后加入TMB底物顯色。TMB在過氧化物酶的催化下轉化成藍色,并在酸的作用下轉化成最終的黃色。顏色的深淺和樣品中的卵泡抑素樣蛋白1(FSTL1)呈正相關。用酶標儀在450nm波長下測定吸光度(O.D.值),計算樣品濃度。
增值服務
相關產品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) | 
| RPJ085Hu01 | 卵泡抑素樣蛋白1(FSTL1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAJ085Hu01 | 卵泡抑素樣蛋白1(FSTL1)多克隆抗體 | WB; IHC; ICC/IF | 
| MAJ085Hu26 | 卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAJ085Hu28 | 卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAJ085Hu27 | 卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | IHC | 
| MAJ085Hu29 | 卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | IHC | 
| MAJ085Hu21 | 卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | WB; IHC | 
| MAJ085Hu22 | 卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | WB; IHC | 
| MAJ085Hu23 | 卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | IHC | 
| MAJ085Hu24 | 卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | IHC | 
| MAJ085Hu25 | 卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | IHC | 
| FAJ085Hu02 | 抗卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | Flow cytometry. | 
| FAJ085Hu04 | 抗卵泡抑素樣蛋白1(FSTL1)單克隆抗體 | Flow cytometry. | 
| SEJ085Hu | 卵泡抑素樣蛋白1(FSTL1)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| WEJ085Hu | 卵泡抑素樣蛋白1(FSTL1)檢測試劑盒(酶聯免疫吸附試驗法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMJ085Hu | 卵泡抑素樣蛋白1(FSTL1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| KSJ085Hu01 | 卵泡抑素樣蛋白1(FSTL1)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | 自己動手制作ELISA試劑盒的主要材料 | 
參考文獻
| 雜志 | 參考文獻 | 
| The Journal of Rheumatology | Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.[PubMed: 22660800] | 
| Archives of Physiology and Biochemistry | Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells[Pubmed: 23419164] | 
| Journal of Proteomics | Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferation[Pubmed:25118038] | 
| PLOS ONE | Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass[Pubmed:25171167] | 
| J Mol Med (Berl) | Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance[PubMed: 26199111] | 
| PLoS One. | Association of Circulating Follistatin-Like 1 Levels with Inflammatory and Oxidative Stress Markers in Healthy Men[pmc:PMC4856269] | 
| JACC:?Basic?to?Translational?Science | Follistatin like?1?Regulates?Hypertrophy?in?Heart?Failure?with?Preserved?Ejection?Fraction.[pubmed:27430031] | 
| Sci Rep | Follistatin like-1 aggravates silica-induced mouse lung injury[PMC5428474] | 
| International Journal of Clinical and Experimental Pathology | Plasma follistatin-like protein 1 is correlated with disease severity in patients with acute pulmonary embolism and predicts short-term mortality[ISSN:1936-2625] | 
| Endocrine?Journal | High circulating follistatin-like protein 1 as a biomarker of a metabolically unhealthy state[Pubmed: 30745500] | 
| PLoS One | Associations among circulating levels of follistatin-like 1, clinical parameters, and cardiovascular events in patients undergoing elective percutaneous?…[Pubmed: 31034503] | 
| British Journal of Cancer | Improved early detection of ovarian cancer using longitudinal multimarker models[Pubmed: 31937926] | 
| Cell Communication and Signaling | Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice[Pubmed: 32933544] | 
| ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY | Effects of acute endurance exercise on follistatin-like 1 and apelin in the circulation and metabolic organs in rats[Pubmed: 32412800] | 
| J Cardiol | Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy[34334268] | 
| Int Heart J | Association between Plasma Follistatin-like Protein 1 Levels and the Presence and Severity of Coronary Artery Disease[34853217] | 





